Capsule Gastric Endoscopy for Gastric Disease Screening in Simulated Home Scenarios

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorNanfang Hospital, Southern Medical University

About this trial

The goal of this clinical trial is to evaluate the diagnostic accuracy of the AI-integrated Capsule Gastroscopy (ACG) system in simulated home-use conditions for detecting upper gastrointestinal (UGI) abnormalities. It will also compare the diagnostic accuracy and time efficiency of AI-assisted interpretation versus manual reading of ACG data. The main questions it aims to answer are:

What is the diagnostic accuracy of the ACG system, using conventional esophagogastroduodenoscopy (EGD) as a standard of reference?

Does AI-assisted ACG reading improve diagnostic accuracy or reduce reading time compared to manual ACG video reading?

Researchers will compare ACG results to conventional EGD findings (standard of reference) to determine if ACG can serve as a reliable method for UGI disease detection in home scenarios.

Participants will:

Undergo an ACG examination in a simulated home environment. Complete an EGD procedure within 24 hours post-ACG ingestion.

Eligibility criteria

Qualifiers

Aged 18 years or older.

Willing to participate voluntarily in the clinical trial and provide written informed consent.

Capable of communicating with researchers and complying with trial requirements.

Disqualifiers

Pregnant individuals.

Individuals at high risk of gastrointestinal obstruction, including those identified as being at risk of gastrointestinal stenosis based on the Gastrointestinal Stenosis Assessment Form, those in whom gastrointestinal obstruction cannot be clinically excluded, or individuals with a history of gastrointestinal surgery, severe motor dysfunction, or pseudobulbar palsy.

Individuals with swallowing dysfunction.

Individuals deemed unfit for surgery or unwilling to undergo any surgical procedures.

Trial design

Treatments tested in this trial

  • AI-integrated Capsule Gastroscopy (ACG) examination
  • Electronic gastroduodenoscopy (EGD) examination

Treatment groups

482 Participants
are divided into 2 treatment groups

Sponsors and collaborators

Nanfang Hospital, Southern Medical University

Lead sponsor

Fondazione Poliambulanza Istituto Ospedaliero

Collaborator

Guangdong Provincial Hospital of Traditional Chinese Medicine

Collaborator

Second Affiliated Hospital of Guangzhou Medical University

Collaborator

ZhuHai Hospital

Collaborator

Pingshan People's Hospital

Collaborator

Ganzhou City People's Hospital

Collaborator

Wuxi People's Hospital

Collaborator

Prince of Wales Hospital, Shatin, Hong Kong

Collaborator

Longgang District People's Hospital of Shenzhen

Collaborator

Mianyang Central Hospital

Collaborator

Renhua People's Hospital

Collaborator